Home › Sezary Syndrome › Georgia
Sezary Syndrome clinical trials in Georgia
4 studies for Sezary Syndrome are looking for participants at sites in Georgia.
Cities in Georgia
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Emory University Medical Center, Atlanta
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
- Emory University Hospital/Winship Cancer Institute, Atlanta
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07003100A Registry for People With T-cell Lymphoma
- Emory University (Data Collection Only), Atlanta
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Extracorporeal Photopheresis in Sezary Syndrome
- Emory University School of Medicine, Atlanta
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Dec 30, 2025 · NCT05157581From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.